Literature DB >> 15843166

Phosphoinositide 3-kinase signaling in the cellular response to oxidative stress.

Andreas Barthel1, Lars-Oliver Klotz.   

Abstract

Oxidative stress is linked to the pathogenesis and pathobiochemistry of various diseases, including cancer, diabetes and cardiovascular disorders. The non-specific damaging effect of reactive oxygen species (ROS) generated during oxidative stress is involved in the development of diseases, as well as the activation of specific signaling cascades in cells exposed to the higher oxidant load. A cellular signaling cascade that is activated by several types of reactive oxygen species is the phosphoinositide 3'-kinase (PI 3-kinase)/protein kinase B (PKB) pathway, which regulates cellular survival and fuel metabolism, thus establishing a link between oxidative stress and signaling in neoplastic, metabolic or degenerative diseases. Several links of PI 3-kinase/PKB signaling to ROS are discussed in this review, with particular focus on the molecular mechanisms involved in the regulation of PI 3-kinase signaling by oxidative stress and important players such as (i) the glutathione and glutaredoxin system, (ii) the thioredoxin system and (iii) Ser/Thr- and Tyr phosphatases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15843166     DOI: 10.1515/BC.2005.026

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  19 in total

Review 1.  Phosphoinositide 3-kinase controls early and late events in mammalian cell division.

Authors:  Zaira García; Amit Kumar; Miriam Marqués; Isabel Cortés; Ana C Carrera
Journal:  EMBO J       Date:  2006-01-26       Impact factor: 11.598

2.  A PI3K pathway mediates hair cell survival and opposes gentamicin toxicity in neonatal rat organ of Corti.

Authors:  Won-Ho Chung; Kwang Pak; Bo Lin; Nicholas Webster; Allen F Ryan
Journal:  J Assoc Res Otolaryngol       Date:  2006-10-20

3.  Retinoic acid stimulation of VEGF secretion from human endometrial stromal cells is mediated by production of reactive oxygen species.

Authors:  Juanjuan Wu; Jason M Hansen; Lijuan Hao; Robert N Taylor; Neil Sidell
Journal:  J Physiol       Date:  2010-12-20       Impact factor: 5.182

4.  Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion.

Authors:  William O Osburn; Nobunao Wakabayashi; Vikas Misra; Tricia Nilles; Shyam Biswal; Michael A Trush; Thomas W Kensler
Journal:  Arch Biochem Biophys       Date:  2006-08-23       Impact factor: 4.013

5.  Silencing of the JNK pathway maintains progesterone receptor activity in decidualizing human endometrial stromal cells exposed to oxidative stress signals.

Authors:  Beatriz Leitao; Marius C Jones; Luca Fusi; Jenny Higham; Yun Lee; Masashi Takano; Tomoko Goto; Mark Christian; Eric W-F Lam; Jan J Brosens
Journal:  FASEB J       Date:  2009-12-21       Impact factor: 5.191

Review 6.  Molecular mechanisms and clinical implications of reversible protein S-glutathionylation.

Authors:  John J Mieyal; Molly M Gallogly; Suparna Qanungo; Elizabeth A Sabens; Melissa D Shelton
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

7.  Molecular mechanism underlying Akt activation in zinc-induced cardioprotection.

Authors:  Sungryul Lee; Guillaume Chanoit; Rachel McIntosh; David A Zvara; Zhelong Xu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-12       Impact factor: 4.733

8.  Molecular responses transduced by serial oxidative stress in the retinal pigment epithelium: feedback control modeling of gene expression.

Authors:  Edward Chaum; Jinggang Yin; John C Lang
Journal:  Neurochem Res       Date:  2010-12-23       Impact factor: 3.996

9.  Titanium dioxide in our everyday life; is it safe?

Authors:  Matej Skocaj; Metka Filipic; Jana Petkovic; Sasa Novak
Journal:  Radiol Oncol       Date:  2011-11-16       Impact factor: 2.991

Review 10.  Magnetic nanoparticles for theragnostics.

Authors:  Veronica I Shubayev; Thomas R Pisanic; Sungho Jin
Journal:  Adv Drug Deliv Rev       Date:  2009-04-20       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.